Survival, non-relapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: Comparing 2003-2007 vs. 2013-2017 cohorts

BACKGROUND: Allogeneic hematopoietic cell transplantation is indicated for refractory hematologic malignancy and some non-malignant disorders. Survival is limited by recurrent malignancy and organ toxicity. OBJECTIVE: We determined whether survival has improved over the last decade and noted impedim...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ann Intern Med
Main Authors: McDonald, George B., Sandmaier, Brenda M., Mielcarek, Marco, Sorror, Mohamed, Pergam, Steven A., Cheng, Guang-Shing, Hingorani, Sangeeta, Boeckh, Michael, Flowers, Mary D., Lee, Stephanie J., Appelbaum, Frederick R., Storb, Rainer, Martin, Paul J., Deeg, H. Joachim, Schoch, Gary, Gooley, Ted A.
Format: Artigo
Sprog:Inglês
Udgivet: 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7847247/
https://ncbi.nlm.nih.gov/pubmed/31958813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M19-2936
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker